{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:49:46Z","timestamp":1792482586212,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Korea Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2025-02273192"],"award-info":[{"award-number":["RS-2025-02273192"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2026-25502802"],"award-info":[{"award-number":["RS-2026-25502802"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2026-25484443"],"award-info":[{"award-number":["RS-2026-25484443"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2024-00332790"],"award-info":[{"award-number":["RS-2024-00332790"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Stem Cell"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.stem.2026.07.002","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T14:42:46Z","timestamp":1784904166000},"page":"1257-1269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dissecting divergent outcomes in stem cell-derived dopamine cell therapy trials for Parkinson\u2019s disease"],"prefix":"10.1016","volume":"33","author":[{"given":"Chan Wook","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanghyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Jong","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil Hyu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5025-1532","authenticated-orcid":false,"given":"Dong-Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.stem.2026.07.002_bib1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S1474-4422(12)70295-8","article-title":"Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease","volume":"12","author":"Barker","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.stem.2026.07.002_bib2","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJM200103083441002","article-title":"Transplantation of embryonic dopamine neurons for severe Parkinson's disease","volume":"344","author":"Freed","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.stem.2026.07.002_bib3","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archneur.1989.00520420033021","article-title":"Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up","volume":"46","author":"Lindvall","year":"1989","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.stem.2026.07.002_bib4","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/ana.410380307","article-title":"Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease","volume":"38","author":"Freeman","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.stem.2026.07.002_bib5","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1093\/brain\/123.7.1380","article-title":"Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease","volume":"123","author":"Brundin","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.stem.2026.07.002_bib6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.10720","article-title":"A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease","volume":"54","author":"Olanow","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.stem.2026.07.002_bib7","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1073\/pnas.1605245113","article-title":"Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain","volume":"113","author":"Li","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.stem.2026.07.002_bib8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1001\/jamaneurol.2013.4749","article-title":"Long-term clinical outcome of fetal cell transplantation for Parkinson disease: two case reports","volume":"71","author":"Kefalopoulou","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.stem.2026.07.002_bib9","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s13311-011-0069-6","article-title":"Cell therapeutics in Parkinson's disease","volume":"8","author":"Lindvall","year":"2011","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.stem.2026.07.002_bib10","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ana.21778","article-title":"Dopaminergic transplantation for Parkinson's disease: current status and future prospects","volume":"66","author":"Olanow","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.stem.2026.07.002_bib11","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/mds.29316","article-title":"First Clinical Report on the Treatment of Parkinson's Disease with Fetal Midbrain Precursor Cells","volume":"38","author":"Kim","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.stem.2026.07.002_bib12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41587-025-02567-2","article-title":"The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson's disease","volume":"44","author":"Barker","year":"2026","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.stem.2026.07.002_bib13","doi-asserted-by":"crossref","DOI":"10.1242\/dev.156117","article-title":"Towards stem cell based therapies for Parkinson's disease","volume":"145","author":"Parmar","year":"2018","journal-title":"Development"},{"key":"10.1016\/j.stem.2026.07.002_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-17165-w","article-title":"Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson's disease","volume":"11","author":"Doi","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.stem.2026.07.002_bib15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.stem.2021.01.004","article-title":"Preclinical Efficacy and Safety of a Human Embryonic Stem Cell-Derived Midbrain Dopamine Progenitor Product, MSK-DA01","volume":"28","author":"Piao","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stem.2026.07.002_bib16","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.stem.2023.08.014","article-title":"Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD","volume":"30","author":"Kirkeby","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stem.2026.07.002_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.stem.2023.11.009","article-title":"Preclinical and dose-ranging assessment of hESC-derived dopaminergic progenitors for a clinical trial on Parkinson's disease","volume":"31","author":"Park","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stem.2026.07.002_bib18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.stem.2025.01.006","article-title":"Pre-clinical safety and efficacy of human induced pluripotent stem cell-derived products for autologous cell therapy in Parkinson's disease","volume":"32","author":"Jeon","year":"2025","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stem.2026.07.002_bib19","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41586-025-08700-0","article-title":"Phase I\/II trial of iPS-cell-derived dopaminergic cells for Parkinson's disease","volume":"641","author":"Sawamoto","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.stem.2026.07.002_bib20","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/s41586-025-08845-y","article-title":"Phase I trial of hES cell-derived dopaminergic neurons for Parkinson's disease","volume":"641","author":"Tabar","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.stem.2026.07.002_bib21","doi-asserted-by":"crossref","first-page":"7036","DOI":"10.1016\/j.cell.2025.09.010","article-title":"Phase 1\/2a clinical trial of hESC-derived dopamine progenitors in Parkinson's disease","volume":"188","author":"Chang","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.stem.2026.07.002_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41531-021-00183-w","article-title":"Persistent dyskinesias in patients with fetal tissue transplantation for Parkinson disease","volume":"7","author":"Greene","year":"2021","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.stem.2026.07.002_bib23","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nbt.3388","article-title":"A comparison of genetically matched cell lines reveals the equivalence of human iPSCs and ESCs","volume":"33","author":"Choi","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.stem.2026.07.002_bib24","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature09342","article-title":"Epigenetic memory in induced pluripotent stem cells","volume":"467","author":"Kim","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.stem.2026.07.002_bib25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.stem.2016.06.019","article-title":"Epigenetic Variation between Human Induced Pluripotent Stem Cell Lines Is an Indicator of Differentiation Capacity","volume":"19","author":"Nishizawa","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stem.2026.07.002_bib26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.gde.2017.07.004","article-title":"Variability of human pluripotent stem cell lines","volume":"46","author":"Ortmann","year":"2017","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.stem.2026.07.002_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41536-022-00221-y","article-title":"Optimizing maturity and dose of iPSC-derived dopamine progenitor cell therapy for Parkinson's disease","volume":"7","author":"Hiller","year":"2022","journal-title":"NPJ Regen. Med."},{"key":"10.1016\/j.stem.2026.07.002_bib28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.stemcr.2017.04.033","article-title":"Cryopreservation Maintains Functionality of Human iPSC Dopamine Neurons and Rescues Parkinsonian Phenotypes In Vivo","volume":"9","author":"Wakeman","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.stem.2026.07.002_bib29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.stem.2016.10.003","article-title":"Single-Cell Analysis Reveals a Close Relationship between Differentiating Dopamine and Subthalamic Nucleus Neuronal Lineages","volume":"20","author":"Kee","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stem.2026.07.002_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-08453-1","article-title":"Single-cell RNA sequencing reveals midbrain dopamine neuron diversity emerging during mouse brain development","volume":"10","author":"Tiklov\u00e1","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.stem.2026.07.002_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adn3057","article-title":"Lineage tracing of stem cell-derived dopamine grafts in a Parkinson's model reveals shared origin of all graft-derived cells","volume":"10","author":"Storm","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.stem.2026.07.002_bib32","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2410331121","article-title":"TARGET-seq: Linking single-cell transcriptomics of human dopaminergic neurons with their target specificity","volume":"121","author":"Fiorenzano","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.stem.2026.07.002_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-04356-8","article-title":"Impact of age at onset on symptom profiles, treatment characteristics and health-related quality of life in Parkinson's disease","volume":"12","author":"Raket","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.stem.2026.07.002_bib34","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1212\/WNL.0000000000006737","article-title":"Age and time course of long-term motor and nonmotor complications in Parkinson disease","volume":"92","author":"Prange","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.stem.2026.07.002_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/mds.70303","article-title":"Prognosis in Parkinson\u2019s Disease: An Individual Patient Data Meta-Analysis of Six European Incidence Cohorts","author":"Macleod","year":"2026","journal-title":"Mov. Disord."},{"key":"10.1016\/j.stem.2026.07.002_bib36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.14802\/jmd.18064","article-title":"Heterogeneous Patterns of Striatal Dopamine Loss in Patients with Young- versus Old-Onset Parkinson's Disease: Impact on Clinical Features","volume":"12","author":"Chung","year":"2019","journal-title":"J. Mov. Disord."},{"key":"10.1016\/j.stem.2026.07.002_bib37","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1915872","article-title":"Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease","volume":"382","author":"Schweitzer","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.stem.2026.07.002_bib38","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.neuron.2019.03.004","article-title":"Circuit Mechanisms of Parkinson's Disease","volume":"101","author":"McGregor","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.stem.2026.07.002_bib39","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJM198804073181402","article-title":"Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications","volume":"318","author":"Kish","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.stem.2026.07.002_bib40","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1002\/mds.110","article-title":"Detecting Mild Cognitive Deficits in Parkinson's Disease: Comparison of Neuropsychological Tests","volume":"33","author":"Hoogland","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.stem.2026.07.002_bib41","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/mds.29565","article-title":"Differential Implications of Cerebral Hypoperfusion and Hyperperfusion in Parkinson's Disease","volume":"38","author":"Jeong","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.stem.2026.07.002_bib42","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/164_2019_331","article-title":"Immunosuppressants in Organ Transplantation","volume":"261","author":"T\u00f6nshoff","year":"2020","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.stem.2026.07.002_bib43","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/s41591-019-0507-2","article-title":"Designing stem-cell-based dopamine cell replacement trials for Parkinson's disease","volume":"25","author":"Barker","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.stem.2026.07.002_bib44","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41422-024-00971-y","article-title":"Past, present, and future of cell replacement therapy for parkinson's disease: a novel emphasis on host immune responses","volume":"34","author":"Park","year":"2024","journal-title":"Cell Res."},{"key":"10.1016\/j.stem.2026.07.002_bib45","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.critrevonc.2005.03.012","article-title":"Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy","volume":"56","author":"Taylor","year":"2005","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.stem.2026.07.002_bib46","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41587-019-0016-3","article-title":"Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients","volume":"37","author":"Deuse","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.stem.2026.07.002_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00926-5","article-title":"MHC matching improves engraftment of iPSC-derived neurons in non-human primates","volume":"8","author":"Morizane","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.stem.2026.07.002_bib48","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.stem.2026.07.002_bib49","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.stem.2026.07.002_bib50","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","article-title":"The genetic architecture of Parkinson's disease","volume":"19","author":"Blauwendraat","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.stem.2026.07.002_bib51","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn3549","article-title":"Parkinson's disease dementia: convergence of \u03b1-synuclein, tau and amyloid-\u03b2 pathologies","volume":"14","author":"Irwin","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.stem.2026.07.002_bib52","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.3233\/JPD-212608","article-title":"Evading the Immune System: Immune Modulation and Immune Matching in Cell Replacement Therapies for Parkinson's Disease","volume":"11","author":"Morizane","year":"2021","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.stem.2026.07.002_bib53","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.stemcr.2013.08.007","article-title":"Direct comparison of autologous and allogeneic transplantation of iPSC-derived neural cells in the brain of a non-human primate","volume":"1","author":"Morizane","year":"2013","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.stem.2026.07.002_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-12324-0","article-title":"MHC matching fails to prevent long-term rejection of iPSC-derived neurons in non-human primates","volume":"10","author":"Aron Badin","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.stem.2026.07.002_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.stemcr.2026.102818","article-title":"The immunological profile of RC17 hESC-derived dopaminergic neural progenitor cells in vitro: Implications for the STEM-PD clinical trial","volume":"21","author":"Curle","year":"2026","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.stem.2026.07.002_bib56","doi-asserted-by":"crossref","DOI":"10.1042\/NS20200083","article-title":"The immunogenicity of midbrain dopaminergic neurons and the implications for neural grafting trials in Parkinson's disease","volume":"5","author":"Qarin","year":"2021","journal-title":"Neuronal Signal."},{"key":"10.1016\/j.stem.2026.07.002_bib57","doi-asserted-by":"crossref","DOI":"10.1186\/s41232-023-00269-3","article-title":"Cell therapy for Parkinson's disease with induced pluripotent stem cells","volume":"43","author":"Morizane","year":"2023","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.stem.2026.07.002_bib58","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41586-023-06300-4","article-title":"Co-transplantation of autologous T(reg) cells in a cell therapy for Parkinson's disease","volume":"619","author":"Park","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.stem.2026.07.002_bib59","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.stem.2025.07.012","article-title":"Control of immune response in an iPSC-based allogeneic cell therapy clinical trial for Parkinson's disease","volume":"32","author":"Morizane","year":"2025","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stem.2026.07.002_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.00250","article-title":"Is the Immunological Response a Bottleneck for Cell Therapy in Neurodegenerative Diseases?","volume":"14","author":"Salado-Manzano","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.stem.2026.07.002_bib61","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ajt.2022.11.013","article-title":"Clinical recommendations for posttransplant assessment of anti-HLA (Human Leukocyte Antigen) donor-specific antibodies: A Sensitization in Transplantation: Assessment of Risk consensus document","volume":"23","author":"Lefaucheur","year":"2023","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.stem.2026.07.002_bib62","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3727\/096368913X676222","article-title":"Donor-Specific Anti-HLA Antibodies in Huntington's Disease Recipients of Human Fetal Striatal Grafts","volume":"24","author":"Porfirio","year":"2015","journal-title":"Cell Transplant."},{"key":"10.1016\/j.stem.2026.07.002_bib63","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","article-title":"Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies","volume":"18","author":"Nalls","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.stem.2026.07.002_bib64","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson's disease","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.stem.2026.07.002_bib65","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41583-024-00812-2","article-title":"Key genes and convergent pathogenic mechanisms in Parkinson disease","volume":"25","author":"Coukos","year":"2024","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.stem.2026.07.002_bib66","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nm1747","article-title":"Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease","volume":"14","author":"Kordower","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.stem.2026.07.002_bib67","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nm1746","article-title":"Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation","volume":"14","author":"Li","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.stem.2026.07.002_bib68","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms5755","article-title":"Glucocerebrosidase depletion enhances cell-to-cell transmission of \u03b1-synuclein","volume":"5","author":"Bae","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.stem.2026.07.002_bib69","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1093\/brain\/awx118","article-title":"Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression","volume":"140","author":"Fereshtehnejad","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.stem.2026.07.002_bib70","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/mdc3.13994","article-title":"Motor and Non-motor Outcomes of Deep Brain Stimulation across the Genetic Panorama of Parkinson's Disease: A Multi-Scale Meta-Analysis","volume":"11","author":"Asimakidou","year":"2024","journal-title":"Mov. Disord. Clin. Pract."},{"key":"10.1016\/j.stem.2026.07.002_bib71","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.7800","article-title":"Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease: A Systematic Review and Meta-analysis","volume":"2","author":"Artusi","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.stem.2026.07.002_bib72","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000214036","article-title":"Long-Term Motor and Cognitive Outcome of Deep Brain Stimulation in Patients With Parkinson Disease With a GBA1 Pathogenic Variant","volume":"105","author":"Avenali","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.stem.2026.07.002_bib73","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/mds.25534","article-title":"Imaging: What can it tell us about parkinsonian gait?","volume":"28","author":"Bohnen","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.stem.2026.07.002_bib74","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1212\/WNL.0b013e31827b1a07","article-title":"Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia","volume":"80","author":"Gomperts","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.stem.2026.07.002_bib75","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1016\/j.cell.2024.05.030","article-title":"TNF-NF-\u03baB-p53 axis restricts in vivo survival of hPSC-derived dopamine neurons","volume":"187","author":"Kim","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.stem.2026.07.002_bib76","doi-asserted-by":"crossref","DOI":"10.1002\/bies.202400118","article-title":"The history and status of dopamine cell therapies for Parkinson's disease","volume":"46","author":"Barker","year":"2024","journal-title":"BioEssays"},{"key":"10.1016\/j.stem.2026.07.002_bib77","doi-asserted-by":"crossref","DOI":"10.1038\/s41536-017-0028-x","article-title":"Translational considerations in injectable cell-based therapeutics for neurological applications: concepts, progress and challenges","volume":"2","author":"Amer","year":"2017","journal-title":"NPJ Regen. Med."},{"key":"10.1016\/j.stem.2026.07.002_bib78","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3233\/JPD-230328","article-title":"Dopaminergic Cell Replacement for Parkinson's Disease: Addressing the Intracranial Delivery Hurdle","volume":"14","author":"Maheshwari","year":"2024","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.stem.2026.07.002_bib79","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/brain\/117.3.487","article-title":"Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon","volume":"117","author":"Peschanski","year":"1994","journal-title":"Brain"},{"key":"10.1016\/j.stem.2026.07.002_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120707","article-title":"Neurothreads: Development of supportive carriers for mature dopaminergic neuron differentiation and implantation","volume":"270","author":"Filippova","year":"2021","journal-title":"Biomaterials"}],"container-title":["Cell Stem Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1934590926002626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1934590926002626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:19:19Z","timestamp":1790165959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1934590926002626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":80,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1934590926002626"],"URL":"https:\/\/doi.org\/10.1016\/j.stem.2026.07.002","relation":{},"ISSN":["1934-5909"],"issn-type":[{"value":"1934-5909","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dissecting divergent outcomes in stem cell-derived dopamine cell therapy trials for Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Cell Stem Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.stem.2026.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}